Workshop 3
Antiviral therapy and resistance 1

Programme

• 15:45 – 16:00 12 Min. 3 Min.

  • Abstract talk
  • O 013

  Fusion inhibitory peptides protect against SARS-CoV-2 Omicron BA.5 transmission in hamsters

  • Kim Handrejk (Rotterdam / NL)

   Antiviral therapy and resistance
• 16:00 – 16:15 12 Min. 3 Min.

  • Abstract talk
  • O 014

  Engineered defective interfering particles of influenza A virus for antiviral treatment

  • Tanya Dogra (Magdeburg / DE)

   Antiviral therapy and resistance
• 16:15 – 16:30 12 Min. 3 Min.

  • Abstract talk
  • O 015

  Identification of a binding pocket of Letermovir inthe small terminase subunit pUL56 of HCMV

  • Lukas Kmetsch (Berlin / DE)

   Antiviral therapy and resistance
• 16:30 – 16:45 12 Min. 3 Min.

  • Abstract talk
  • O 016

  Construction and evaluation of murine Cytomegalovirus-targeting Bispecific T cell engagers (BiTE)

  • Hanna Menschikowski (Erlangen / DE)

   Antiviral therapy and resistance
• 16:45 – 17:00 12 Min. 3 Min.

  • Abstract talk
  • O 017

  Cyclin-dependent kinase 8 (CDK8) as a target of novel anti-cytomegalovirus strategies

  • Debora Obergfäll (Erlangen / DE)

   Antiviral therapy and resistance
• 17:00 – 17:15 12 Min. 3 Min.

  • Abstract talk
  • O 018

  Novel small chemical compounds blocking herpes simplex virus assembly

  • Julio Cesar Villalvazo Guerrero (Hannover / DE)

   Antiviral therapy and resistance